Suppr超能文献

非酒精性脂肪性肝病中巨噬细胞的功能多样性——不止炎症那么简单。

Macrophage functional diversity in NAFLD - more than inflammation.

机构信息

Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

出版信息

Nat Rev Endocrinol. 2022 Aug;18(8):461-472. doi: 10.1038/s41574-022-00675-6. Epub 2022 May 9.

Abstract

Macrophages have diverse phenotypes and functions due to differences in their origin, location and pathophysiological context. Although their main role in the liver has been described as immunoregulatory and detoxifying, changes in macrophage phenotypes, diversity, dynamics and function have been reported during obesity-related complications such as non-alcoholic fatty liver disease (NAFLD). NAFLD encompasses multiple disease states from hepatic steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis and hepatocarcinoma. Obesity and insulin resistance are prominent risk factors for NASH, a disease with a high worldwide prevalence and no approved treatment. In this Review, we discuss the turnover and function of liver-resident macrophages (Kupffer cells) and monocyte-derived hepatic macrophages. We examine these populations in both steady state and during NAFLD, with an emphasis on NASH. The explosion in high-throughput gene expression analysis using single-cell RNA sequencing (scRNA-seq) within the last 5 years has revolutionized the study of macrophage heterogeneity, substantially increasing our understanding of the composition and diversity of tissue macrophages, including in the liver. Here, we highlight scRNA-seq findings from the last 5 years on the diversity of liver macrophages in homeostasis and metabolic disease, and reveal hepatic macrophage function beyond their classically described inflammatory role in the progression of NAFLD and NASH pathogenesis.

摘要

巨噬细胞因其起源、位置和病理生理背景的不同而具有不同的表型和功能。尽管它们在肝脏中的主要作用是免疫调节和解毒,但在肥胖相关并发症(如非酒精性脂肪性肝病,NAFLD)中,巨噬细胞表型、多样性、动态和功能的变化已经被报道。NAFLD 包括从肝脂肪变性到非酒精性脂肪性肝炎(NASH)、纤维化、肝硬化和肝癌等多种疾病状态。肥胖和胰岛素抵抗是 NASH 的突出危险因素,这是一种在全球范围内发病率较高且尚无批准治疗方法的疾病。在这篇综述中,我们讨论了肝脏驻留巨噬细胞(Kupffer 细胞)和单核细胞衍生的肝巨噬细胞的更新和功能。我们在稳态和 NAFLD 期间检查了这些细胞群,重点是 NASH。在过去的 5 年中,利用单细胞 RNA 测序(scRNA-seq)进行高通量基因表达分析的爆炸式发展彻底改变了对巨噬细胞异质性的研究,大大提高了我们对组织巨噬细胞组成和多样性的理解,包括在肝脏中。在这里,我们强调了过去 5 年中关于稳态和代谢性疾病中肝脏巨噬细胞多样性的 scRNA-seq 研究结果,并揭示了肝巨噬细胞的功能超越了其在 NAFLD 和 NASH 发病机制进展中经典描述的炎症作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验